Print Page | Close Window

Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

May 24, 2016 - 4:30 p.m.
Gilead Sciences Announces Appointment of Kevin Young CBE as Chief Operating Officer and Martin Silverstein, MD as Executive Vice President, StrategyPrinter Friendly Version 
May 20, 2016 - 5:01 p.m.
Gilead Sciences to Present at the UBS Global Healthcare Conference on Monday, May 23Printer Friendly Version 

Upcoming Events

Friday, June 3, 2016 through Tuesday, June 7, 2016
American Society of Clinical Oncology (ASCO) 2016 Annual Meeting
LocationChicago, IL
Wednesday, June 8, 2016 11:20 a.m. PT
Gilead Sciences at the 37th Annual Goldman Sachs Global Healthcare Conference
LocationRancho Palos Verdes, CA
Friday, June 10, 2016 10:30 a.m. ET
Gilead Sciences at Jefferies 2016 Healthcare Conference
LocationNew York, NY
Tuesday, June 14, 2016 8:10 a.m. CT
Gilead Sciences at William Blair & Company's 2016 Growth Stock Conference
LocationChicago, IL

Most Viewed Links

Updated 05/25/16
1.UBS Global Healthcare Conference
3.Gilead Sciences to Present at the UBS Global Healthcare Conference on Monday, May 23
4.SEC Filings
5.Annual Reports
* Data collected 05/17/16 - 05/24/16

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.